-
1.
公开(公告)号:US20230365714A1
公开(公告)日:2023-11-16
申请号:US18029472
申请日:2021-10-01
Applicant: GENMAB A/S
Inventor: Louise Koopman , Patrick ENGELBERTS , David SATIJN , Jan Hermen DANNENBERG
CPC classification number: C07K16/468 , A61P35/00 , C07K2317/31 , C07K2317/565 , C07K2317/24 , C07K2317/35 , C07K2317/92
Abstract: The present invention relates to antibodies binding to ROR2, including bispecific antibodies binding to ROR2 and CD3. The invention further provides pharmaceutical compositions comprising the antibodies and use of the antibodies for therapeutic and diagnostic procedures, in particular in cancer therapy.